Article info
Screening
Original research
Universal germline testing among patients with colorectal cancer: clinical actionability and optimised panel
- Correspondence to Prof. Pei-Rong Ding, Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China; dingpr{at}sysucc.org.cn; Prof. Zhi-Zhong Pan, Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China; panzhzh{at}sysucc.org.cn
Citation
Universal germline testing among patients with colorectal cancer: clinical actionability and optimised panel
Publication history
- Received June 2, 2020
- Revised January 12, 2021
- Accepted January 16, 2021
- First published February 9, 2021.
Online issue publication
March 23, 2022
Article Versions
- Previous version (9 February 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.